ABILIFY MAINTENA: payments to doctors
Payments that named ABILIFY MAINTENA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $20M
- Providers
- 37,373
- Transactions
- 229,986
- Average per transaction
- $87
The per-transaction average — $87 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 37,373 providers the average total is $534, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $18,176,159 | 91.0% |
| H. Lundbeck A S | $969,709 | 4.9% |
| Lundbeck LLC | $518,692 | 2.6% |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $203,618 | 1.0% |
| Otsuka Pharmaceutical Co., Ltd. | $95,608 | 0.5% |